OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
November 27, 2009
The US Society for Chemical Manufacturers and Affiliates (SOCMA) has provided an update of its efforts regarding the recently passed US Chemical and Water Security Act of 2009 (HR 2868), which includes inherently safer technology (IST) requirements that SOCMA opposes.
November 25, 2009
The Society for Chemical Manufacturers and Affiliates (SOCMA) provided an update as to its grassroots efforts regarding the recently passed Chemical and Water Security Act of 2009 (HR 2868).
November 20, 2009
Following its $68-billion acquisition of Wyeth, Pfizer has unveiled detailed plans for its global R&D network, which includes consolidation of its R&D facilities.
November 19, 2009
Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities.
November 12, 2009
Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical.
The European Medicines Agency, the European Center for Disease Prevention and Control, and the Heads of Medicines Agencies issued a European strategy for H1N1 vaccine benefit–risk monitoring.